Quaker BioVentures, which was founded in 2003, invests across the life science industry and all stages of development. The company is currently investing from Quaker BioVentures II, a $420 million fund it formed in 2007. In the past, the company has typically invested in biopharmaceuticals, but has recently said it is interestested in diversifying its portfolio with medical device and diagnostics companies. The Pennsylvania-based company prefers to work with developers in the Mid-Atlantic or Southeast region.